Best Grants for Capital Funding in Missouri

Founded in 2016, this program supports nonfiction filmmakers or filmmaking teams working on their first or second feature-length documentary.

In this year-long program, 9 filmmakers will receive:

• $40,000 USD in grant funding for the production of their feature-length film
• Mentorship with Chicken & Egg Films team members
• Two creative retreats focused on career building and creative development
• Travel stipend for director and producer upon acceptance to a forum or market during program year
• Tailored industry meetings and funder connections
• Peer support from their cohort

You do not need a fiscal sponsor to apply for the (Egg)celerator Lab. However, if you are selected for the Lab, you must secure a US fiscal sponsor, or be a 501(c)(3), to receive the funds. If granted, we can help advise on finding a fiscal sponsor. 

The Dermatology Foundation offers Career Development Awards to support the academic growth of emerging investigators in various dermatologic fields. With an annual stipend of $55,000, these awards foster research addressing significant health issues, including public health, diversity, and women's health. Eligible applicants must demonstrate strong institutional support and meet specific educational requirements. The awards can be renewed for up to three years, contingent on the recipient's progress and commitment to advancing dermatological science.

The Medical Student Research Supplement Award by the Dermatology Foundation supports medical students' research in dermatology, encouraging diversity and inclusion. This award offers $5,000 for direct research expenses, fostering the involvement of full-time students from underrepresented backgrounds. Eligible applicants must be current or former DF career development awardees and must recruit medical students pursuing MD or DO degrees who meet specific academic criteria. The award enhances research participation and strengthens the academic workforce in dermatology.

The Early Career Research Development Grant from the Emergency Medicine Foundation supports early career faculty in developing comprehensive career plans and leading impactful research projects. With over $20 million awarded since its inception, EMF aims to enhance emergency medicine research and improve health policy. This grant encourages partnerships between research universities and community emergency departments, fostering collaboration that promotes patient care and effective health policy.

American Gastroenterological Association

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization.

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

This award provides funding for three years to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in inflammatory bowel disease (IBD) research.

Objective

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). This award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research pertaining to inflammatory bowel disease.

Review all of the benefits AGA Research Scholar Award recipients are entitled to on the award policies page.

Application Requirements

• Maintain AGA membership throughout the three-year duration of the award.

• Applicants must self-assign their proposal to one of the following categories:
  • Clinical: Research involving direct contact with human subjects or using clinical data to address problems related to the prevention, diagnosis, treatment or outcome of human diseases (e.g., clinical epidemiology). This category also includes research related to health care delivery (e.g., health services, health IT).
  • Basic/Translational: Research with a primary goal of understanding basic biology or disease mechanisms. This category can involve animal subjects, cell culture, human biospecimens or human data as resources for laboratory- or informatics-based investigation.

• Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 50 percent effort to the proposed project.

• Applicants are required to have a sponsor and mentor for the award; one individual may serve in the capacity of both positions. A sponsor (typically a division chief or department chair) is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables and will work with the applicant to create a research career development plan.

• The intent of this award is to foster the scientific independence of junior investigators. Applicants whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It must also be clearly stated how the work submitted by the applicant is that of the applicant and not that of the senior mentor(s).

• A complete research facilities and resources form must be submitted.

• Biographical sketches for the applicant, mentor and other key personnel must be submitted.

• Applicants resubmitting a revised application from a prior cycle must include a resubmission report describing responses to reviewer feedback and other major changes since the most recent past submission.

• Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee(s) for use of human subjects or animals. If approval is not necessary, then the recipient must provide documentation from the appropriate regulatory committee.

• Recipients must submit scientific and financial progress reports to AGA annually and final reports 60 days after the end date of the award period. Report templates and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.

• All publications, presentations, abstracts, and patent applications arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.

• Additional pre-award policies are available on the Research Award Policies page.

Award Overlap

• At the time of application submission, applicants may not hold, or have held, an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (e.g., the American Liver Foundation, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation).

• Applicants who have held a K12 or KL2 in the past are eligible to apply. Applicants with an active K12 or KL2 may apply in the final year of their active K12 or KL2 so long as the award will end before the Research Scholar Award term begins.

• If a applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, then the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

• If the recipient is notified that a comparable award has been granted after the first payment of this award, then the recipient may retain up to 50 percent of the remainder of his or her AGA award. AGA must be notified by the recipient via email within two weeks of receiving notification of additional funding.

The Philip Keenan Award, presented by the American Orchid Society, honors individuals dedicated to studying or preserving native orchids in North America. This prestigious award acknowledges past accomplishments in these fields, promoting broader appreciation for orchids and supporting ongoing conservation efforts. Applicants can include students, amateurs, or professionals who demonstrate commitment and passion for orchid research and preservation, contributing to the sustainability of these beautiful plants.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Acute Myeloid Leukemia (AML) Fund

Help with healthcare costs for acute myeloid leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Chronic Lymphocytic Leukemia (CLL) Fund

Help with healthcare costs for chronic lymphocytic leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See Approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Fund

Help with healthcare costs for hemophilia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Every Battle Creek area resident shall have the resources to access post-secondary education and training.

Your dreams matter — and we want to help you achieve them. Whether you’re a graduating high school senior, an adult returning to school, or a graduate student pursuing advanced education, we’re here to support you by opening doors to opportunity.

Beyond tuition, many funds support total cost of attendance — books, fees, equipment, and in some cases childcare or transportation.

Checks are made payable to the educational institution indicated on the follow-up and mailed directly to the educational institution. Checks are typically mailed in early August.

Kay Earline Vanderford Nursing Scholarship Fund

The Kay Earline Vanderford Nursing Scholarship Fund was established in 2011 in loving memory of Kay Earline Vanderford by her son Douglas Vanderford. A graduate of Kellogg Community College's nursing program, Kay Earline Vanderford worked as a LPN for several years at area nursing homes. She served the Homer and Litchfield communities most of her life and was very compassionate toward her patients. This scholarship assists those who are called to enter the field of nursing.

The Chan Zuckerberg Initiative is calling for innovative research proposals that leverage synthetic biology principles to advance immunology. This funding opportunity supports projects aimed at enhancing immune cell functionality, developing synthetic bio-circuits, and creating artificial immune systems. The initiative seeks transformative research that can lead to significant breakthroughs in understanding and treating immune-related diseases, ultimately impacting public health on a large scale.

The American Italian Cancer Foundation (AICF) offers a prestigious International Post-doc Research Fellowship Program aimed at supporting innovative research in cancer biology and treatment. Open to Italian citizens with advanced degrees obtained within the last three years, the program encourages applications for both basic and clinical research. Typically, applications are accepted from January to February, with fellowships granted for one year, potentially extendable for a second year.

The Bladder Cancer Research Innovation Award, funded by the Bladder Cancer Advocacy Network Inc, promotes innovative, high-risk projects aimed at advancing bladder cancer research. This two-year grant encourages novel methodologies and interventions that tackle critical barriers and knowledge gaps in the field. Eligible projects should demonstrate direct relevance to bladder cancer and upper tract urothelial carcinoma, fostering breakthroughs that could significantly enhance understanding and treatment of this disease.

The Patient-Centered Clinical Research Young Investigator Award (PCC-YIA) supports early-career scientists conducting innovative research in bladder cancer and upper tract urothelial cancer. This award facilitates studies focusing on patient-centered outcomes, quality of care, and health disparities. Eligible applicants must be within six years of their professional degree and have mentorship from an approved institution. The award promotes transformative research aimed at improving patient experiences and outcomes in clinical settings.

The Bladder Cancer Young Investigator Awards, funded by the Bladder Cancer Advocacy Network, provide $50,000 to early career researchers in various scientific fields. These awards aim to foster innovation and collaboration in bladder cancer research, ultimately improving outcomes for patients. Eligible applicants include those within six years of completing their degrees and who do not hold the title of Associate Professor or higher. This initiative underscores BCAN's commitment to advancing bladder cancer research and supporting promising investigators.

The McCarthey Dressman Education Foundation offers Academic Enrichment Grants to support innovative educational programs that enhance student learning for low-income children. These grants, up to $10,000 per year for two years, aim to foster creativity and critical thinking in K-12 education. Applications are accepted from educators at nonprofit organizations who engage with students directly. The initiative emphasizes collaboration and seeks projects that enrich academic experiences and inspire student curiosity.

The ASH Quality Improvement Training Institute (QITI) is a 16-month hybrid training program designed for North American hematology care teams. It aims to empower clinicians as leaders in quality improvement, enhancing patient outcomes and experiences. Participants engage in in-person and virtual workshops, collaborating with faculty to develop clinical quality improvement projects. Key curriculum highlights include multi-disciplinary team strategies, quality improvement assessment tools, and skills for presenting QI work effectively.

The ASH Research Training Award for Fellows (RTAF) supports junior researchers in hematology and hematology-related fields. It offers $70,000 for one year, ensuring dedicated research time. Eligible MD and MD-PhD fellows can apply for a second year, aiding their competitiveness for further awards. The program emphasizes research in hematologic conditions and requires documented mentorship support. Awardees also receive $1,000 for ASH annual meeting attendance, fostering networking and professional development.

The Hematology Inclusion Pathway Fellow Award supports early-career researchers from underrepresented communities in hematology in the U.S. and Canada. Offering up to $100,000 over two to three years, the award enables fellows to focus on hematology research and enhance their competitiveness for future awards. Eligible applicants include those with relevant degrees, who are in their first or second fellowship year, and have a committed ASH member mentor. This initiative aims to diversify the field of academic hematology.

The ASH Medical Educators Institute Grant Program aims to cultivate future leaders in hematology education through a comprehensive training initiative. This program includes workshops, webinars, and mentorship, designed for junior faculty and senior fellows in the U.S. and Canada. Participants enhance their teaching skills, develop scholarly projects, and build valuable professional networks. The initiative promotes diversity in medical education and seeks to empower educators dedicated to advancing the field of hematology.

The ASH Graduate Hematology Award supports graduate students in the U.S. and Canada pursuing research in hematology. Offering a $40,000 annual stipend for two years, it covers tuition, research expenses, and travel to the ASH Annual Meeting. Eligible applicants must be PhD students in their first three years and have a mentor's support. This award aims to foster careers in academic hematology, encouraging innovative research in various hematologic fields.

The ASH Medical Student Physician-Scientist Award offers first-, second-, and third-year medical students a unique chance to engage in hematology research under the mentorship of an ASH member. This year-long project requires recipients to dedicate over 80% of their time to research, with funding totaling $42,000 for various expenses. Eligible candidates must be ASH members and actively enrolled in accredited medical programs in the U.S. or Canada, aiming for a career in hematology.

The ASHP Foundation offers Professional Advancement Scholarships for up to 13 graduating pharmacy students to attend the 2025 ASHP Midyear Clinical Meeting. Each recipient will receive full meeting registration and $1,000 for travel expenses. This initiative aims to enhance professional development and networking opportunities for future pharmacists, facilitating their engagement with the pharmacy community and furthering their education in patient care.

The NIH's TALK initiative aims to enhance clinical practices for late talking children by funding research to identify early signs of language delays. This NOFO focuses on developing evidence-based strategies for screening and supporting children and their families. It targets children over 18 months who are not meeting language milestones, particularly those at higher risk due to various factors. Collaborative research efforts are encouraged to ensure effective identification and intervention.

U.S. Civil Society Microgrants

We seek to support projects that engage Pulitzer Center journalism to amplify the voices of affected communities, foster public debate, and drive meaningful audience engagement with our focus areas.

Audience engagement has been at the core of the Pulitzer Center’s work since its founding in 2006. In addition to grants and fellowships that facilitate breakthrough journalism, we support initiatives that connect the reporting to the audiences that need it the most. Our goal is pursuing real-world impact: engaging and mobilizing communities, increasing understanding and connection, and influencing decisions locally and globally. 

This microgrant aims to support civil society organizations and groups in the United States to utilize Pulitzer Center-supported reporting as part of projects that contribute to a more informed and empowered community.

 For this grant cycle, we are seeking grant proposals for civic engagement projects to be completed by early December 2026 that focus on one of the following issues:

• Climate and the environment, with a focus on U.S fisheries and fishing communities or climate and labor
• Information and Artificial Intelligence
• Global health, with specific focus on mental well-being or connections to the Global South

The objective is to use Pulitzer Center-supported journalism as the inspiration for the projects supported by this civil society microgrant. By leveraging this reporting, we expect to build projects that amplify the voices of affected communities, foster public debate, and drive meaningful audience engagement that will lead to impactful conversations in communities in the U.S. and beyond.

Grants range from US$2,000 to US$4,000. Project proposals can support existing activities or support the launch of new activities. 

The Preserving Black Churches Grant Program, managed by the National Trust for Historic Preservation, aims to support the preservation of historic Black churches. Grants range from $50,000 to $500,000 and fund various projects, including restoration, capacity building, and community engagement. The program encourages applications from active and non-active congregations, nonprofits, and public agencies, emphasizing the importance of these churches in their communities. This initiative seeks to strengthen heritage and foster cultural connections.

About The Community Foundation

The Community Foundation of Herkimer and Oneida Counties is a community-based social impact investor whose mission is to engage, invest, and lead—working toward a vision of community vibrancy with opportunity for all. Our team of experienced staff and dedicated trustees is committed to boldly leading and supporting transformational community investments. We channel charitable contributions from donors through nonprofit partners that are meeting current community needs and steward community resources responsibly to ensure greater capacity for the future.

Adirondack League Club Scholarship

Established by Adirondack League Club to award scholarships to students in the Central Adirondack region of the Adirondack Park.

Candidates are identified by a committee.